early detection

Oncology

Interview at ASCO 26 with David Spetzler

ASCO26: AI supercharging gene-based cancer detection, with D...

Pharmaphorum caught up with Caris Life Science's David Spetzler to talk about how agentic AI is empowering whole genome sequencing in cancer detection

R&D

Beyond proof of concept: Alzheimer’s and the next chapter of...

Research has demonstrated that some individuals at elevated risk of Alzheimer's disease can be identified before symptoms emerge.

R&D

Trajectory-based diagnostics enable early intervention in pr...

Diagnostic testing in modern medicine remains largely episodic and threshold-based.

R&D

Advancements in early detection and innovative therapies tar...

Alzheimer’s disease (AD) robs millions of individuals of their memories, cognitive function, and independence, placing an immense emotional and financial burden on families and healthcare s

News